Lauren  Budden net worth and biography

Lauren Budden Biography and Net Worth

Group Vice President, CAO and Controller of Insulet

Ms. Budden has served as Group Vice President, Chief Accounting Officer and Controller since March 2022, and previously as our Vice President, Chief Accounting Officer and Controller since  April 2019. She also served as our Interim Chief Financial Officer and Treasurer from October 2023 to April 2024. Prior to joining Insulet, Ms. Budden served as Vice President and Chief Accounting Officer at Gulf Oil since 2016, a privately held distributor of motor fuels. From 2007 to 2016, Ms. Budden held roles of increasing responsibility at Medtronic and Covidien plc (acquired by Medtronic in 2015), including Vice President, Financial Planning and Analysis for Medtronic plc’s Minimally Invasive Therapies Group and Vice President, External Reporting at Covidien. Ms. Budden began her career with PricewaterhouseCoopers. She received her Bachelor of Science from Boston College and her Master of Business Administration from the University of Massachusetts, Amherst. Ms. Budden is a Certified Public Accountant.

What is Lauren Budden's net worth?

The estimated net worth of Lauren Budden is at least $1.60 million as of December 10th, 2024. Ms. Budden owns 5,733 shares of Insulet stock worth more than $1,598,876 as of January 22nd. This net worth estimate does not reflect any other assets that Ms. Budden may own. Additionally, Ms. Budden receives an annual salary of $794,050.00 as Group Vice President, CAO and Controller at Insulet. Learn More about Lauren Budden's net worth.

How old is Lauren Budden?

Ms. Budden is currently 49 years old. There are 9 older executives and no younger executives at Insulet. The oldest executive at Insulet is Mr. John Wodick Kapples, Senior VP & General Counsel, who is 64 years old. Learn More on Lauren Budden's age.

What is Lauren Budden's salary?

As the Group Vice President, CAO and Controller of Insulet Co., Ms. Budden earns $794,050.00 per year. There are 4 executives that earn more than Ms. Budden. The highest earning executive at Insulet is Dr. James R. Hollingshead Ph.D., President, CEO & Director, who commands a salary of $2,880,000.00 per year. Learn More on Lauren Budden's salary.

How do I contact Lauren Budden?

The corporate mailing address for Ms. Budden and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at ir@insulet.com. Learn More on Lauren Budden's contact information.

Has Lauren Budden been buying or selling shares of Insulet?

Lauren Budden has not been actively trading shares of Insulet within the last three months. Most recently, Lauren Budden sold 915 shares of the business's stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $275.62, for a transaction totalling $252,192.30. Following the completion of the sale, the chief accounting officer now directly owns 5,733 shares of the company's stock, valued at $1,580,129.46. Learn More on Lauren Budden's trading history.

Who are Insulet's active insiders?

Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Lauren Budden (Group Vice President, CAO and Controller), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.

Are insiders buying or selling shares of Insulet?

In the last twelve months, insiders at the medical instruments supplier sold shares 7 times. They sold a total of 38,849 shares worth more than $8,250,136.91. The most recent insider tranaction occured on January, 21st when EVP Eric Benjamin sold 12,394 shares worth more than $3,470,320.00. Insiders at Insulet own 0.5% of the company. Learn More about insider trades at Insulet.

Information on this page was last updated on 1/21/2025.

Lauren Budden Insider Trading History at Insulet

See Full Table

Lauren Budden Buying and Selling Activity at Insulet

This chart shows Lauren Budden's buying and selling at Insulet by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k-$100k$0$100k$200kTotal Insider BuyingTotal Insider Selling

Insulet Company Overview

Insulet logo
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Read More

Today's Range

Now: $278.89
Low: $274.36
High: $279.68

50 Day Range

MA: $266.32
Low: $256.44
High: $276.08

2 Week Range

Now: $278.89
Low: $160.19
High: $282.86

Volume

562,185 shs

Average Volume

537,014 shs

Market Capitalization

$19.56 billion

P/E Ratio

47.76

Dividend Yield

N/A

Beta

1.22